Check Cap Ltd (NASDAQ:CHEK) posted its quarterly earnings results on Wednesday. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.14) by $0.03.

Shares of Check Cap (NASDAQ:CHEK) opened at 2.62 on Thursday. The stock has a 50 day moving average price of $2.06 and a 200 day moving average price of $1.88. The stock’s market cap is $32.11 million. Check Cap has a 12 month low of $0.97 and a 12 month high of $3.72.

A number of equities research analysts have issued reports on CHEK shares. Maxim Group boosted their price target on Check Cap from $6.00 to $11.00 and gave the company a “buy” rating in a research report on Monday, August 1st. Zacks Investment Research downgraded Check Cap from a “buy” rating to a “hold” rating in a research report on Wednesday, July 20th.

Check Cap Company Profile

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.

5 Day Chart for NASDAQ:CHEK

Receive News & Stock Ratings for Check Cap Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap Ltd and related stocks with our FREE daily email newsletter.